New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2013
13:25 EDTDVA, DVA, DVA, HCA, HCA, HCA, HUM, HUM, HUMLeerink's healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gurda provides a perspective on the recently proposed 2014 Medicare Advantage (MA) rates and provides an update on healthcare reform on an Analyst/Industry conference call to be held on March 7 at 2 pm.
News For DVA;HCA;HUM From The Last 14 Days
Check below for free stories on DVA;HCA;HUM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 12, 2014
12:04 EDTHUMHumana management to meet with Jefferies
Subscribe for More Information
10:00 EDTHCAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:22 EDTHCAHCA Holdings initiated with an Outperform at Leerink
Subscribe for More Information
September 10, 2014
08:42 EDTHUMHumana says all 2015 Medicare Advantage, PDP offerings approved
Subscribe for More Information
September 9, 2014
12:14 EDTHCAHospitals rise after analyst says positive trends continuing
Subscribe for More Information
07:37 EDTHCADeutsche Bank ups price targets in Hospital space
Subscribe for More Information
September 8, 2014
07:26 EDTHCAMorgan Stanley to hold a conference
Subscribe for More Information
September 5, 2014
07:56 EDTHUMHumana likely to add new growth drivers, says Wells Fargo
Subscribe for More Information
September 4, 2014
12:49 EDTHUMJudges to revisit ObamaCare subsidies decision, The Hill reports
Subscribe for More Information
September 3, 2014
14:55 EDTHUMObamaCare business exchange to launch in 5 states next month, The Hill says
Subscribe for More Information
06:34 EDTHUMNext Obamacare enrollment period may be very difficult, NY Times says
Subscribe for More Information
September 2, 2014
08:34 EDTHUMHumana to reaffirm FY14 EPS view $7.25-$7.75, consensus $7.73
Members of Humana Inc.’s senior management team are scheduled to meet with investors at various times between September 3 and the end of the month. During such meetings, Humana’s management expects to reaffirm its guidance of $7.25-$7.75 in diluted EPS for the year ending December 31, 2014. This EPS guidance is consistent with that issued in Humana’s current report on Form 8-K filed with the U.S. SEC on July 30 and subsequently reiterated in investor presentations posted to the Investor Relations section of its web site.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use